C4 Therapeutics CCCC
NASDAQ CCCC
$3.14 +0.00 (+0.16%)
As of: Oct 2, 2026 · 1:24 PM EDT

C4 Therapeutics (CCCC) Other Non Operating Income (2019 - 2023)

Updated

C4 Therapeutics' Other Non Operating Income came in at -$621,000 for FY2023.

Analysis

C4 Therapeutics (CCCC) Other Non Operating Income (2019 - 2023) Analysis & Trends

  • The FY2023 figure represents the highest annual Other Non Operating Income since FY2020.
  • Per Business Quant, earlier years put Other Non Operating Income at $5.68 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 C4 Therapeutics 409.28 Mn -520.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -621,000.00
Dec 31, 2020 2.54 Mn
Sep 30, 2020 3.14 Mn
Sep 30, 2019 -1,000.00
API Access

C4 Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=CCCC&period=max&api_key=YOUR_API_KEY